Renal Cancer
Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma.
October 12, 2021
Identification of Prognostic Metabolism-Related Genes in Clear Cell Renal Cell Carcinoma.
October 8, 2021
Parenchymal Volume Replacement by Renal Cell Carcinoma Prior to Intervention: Predictive Factors and Functional Implications.
October 7, 2021
Inflammatory response markers and survival prediction in patients with renal cell carcinoma.
October 5, 2021
CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.
October 5, 2021
Limited Association Between Ascorbate Concentrations and Vitamin C Transporters in Renal Cell Carcinoma Cells and Clinical Samples.
October 4, 2021
Morphomics Can Predict Oncological Features and Survival of Metastatic Renal Cell Carcinoma After Cytoreductive Nephrectomy.
October 4, 2021
Predictive radiomics signature for treatment response to nivolumab in patients with advanced renal cell carcinoma.
October 1, 2021
Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade.
October 1, 2021
Evaluation of the association of health care system access with kidney cancer surgical outcomes for hispanic and non-hispanic white patients.
September 30, 2021